165 related articles for article (PubMed ID: 11596451)
41. Pathophysiology of fatty acid oxidation disorders.
Bennett MJ
J Inherit Metab Dis; 2010 Oct; 33(5):533-7. PubMed ID: 20824345
[TBL] [Abstract][Full Text] [Related]
42. Influence of dietary fatty acid chain-length on metabolic tolerance in mouse models of inherited defects in mitochondrial fatty acid beta-oxidation.
Schuler AM; Gower BA; Matern D; Rinaldo P; Wood PA
Mol Genet Metab; 2004 Dec; 83(4):322-9. PubMed ID: 15589119
[TBL] [Abstract][Full Text] [Related]
43. [Short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD) deficiency].
Takusa Y; Yamaguchi S
Ryoikibetsu Shokogun Shirizu; 2001; (36):74-6. PubMed ID: 11596455
[No Abstract] [Full Text] [Related]
44. [Very-long-chain acyl-CoA dehydrogenase deficiency].
Uchiyama A; Takusa Y; Yamaguchi S
Ryoikibetsu Shokogun Shirizu; 2001; (36):65-7. PubMed ID: 11596452
[No Abstract] [Full Text] [Related]
45. Impact of fatty acid oxidation disorders in child neurology: from Reye syndrome to Pandora's box.
Tein I
Dev Med Child Neurol; 2015 Apr; 57(4):304-6. PubMed ID: 25761966
[No Abstract] [Full Text] [Related]
46. 3,5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement.
Lombardi A; de Lange P; Silvestri E; Busiello RA; Lanni A; Goglia F; Moreno M
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E497-502. PubMed ID: 19116374
[TBL] [Abstract][Full Text] [Related]
47. Reye syndrome versus defects in oxidation of fatty acids.
Wilson BE; Anderson LW
J Pediatr; 1986 Jan; 108(1):159. PubMed ID: 3944684
[No Abstract] [Full Text] [Related]
48. Fifty years of research on mitochondrial fatty acid oxidation disorders: The remaining challenges.
Vianey-Saban C; Guffon N; Fouilhoux A; Acquaviva C
J Inherit Metab Dis; 2023 Sep; 46(5):848-873. PubMed ID: 37530674
[TBL] [Abstract][Full Text] [Related]
49. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation.
Houten SM; Wanders RJ
J Inherit Metab Dis; 2010 Oct; 33(5):469-77. PubMed ID: 20195903
[TBL] [Abstract][Full Text] [Related]
50. Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases.
Shekhawat P; Bennett MJ; Sadovsky Y; Nelson DM; Rakheja D; Strauss AW
Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1098-105. PubMed ID: 12582009
[TBL] [Abstract][Full Text] [Related]
51. The laboratory diagnosis of inborn errors of mitochondrial fatty acid oxidation.
Bennett MJ
Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():519-31. PubMed ID: 2080855
[No Abstract] [Full Text] [Related]
52. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.
Koves TR; Ussher JR; Noland RC; Slentz D; Mosedale M; Ilkayeva O; Bain J; Stevens R; Dyck JR; Newgard CB; Lopaschuk GD; Muoio DM
Cell Metab; 2008 Jan; 7(1):45-56. PubMed ID: 18177724
[TBL] [Abstract][Full Text] [Related]
53. Mitochondrial fatty acid oxidation disorders. Proceedings of an international symposium. October 2008. Fulda, Germany.
J Inherit Metab Dis; 2010 Oct; 33(5):467-634. PubMed ID: 21275107
[No Abstract] [Full Text] [Related]
54. Peroxisomes, lipid metabolism, and peroxisomal disorders.
Wanders RJ
Mol Genet Metab; 2004; 83(1-2):16-27. PubMed ID: 15464416
[TBL] [Abstract][Full Text] [Related]
55. [The contribution of biochemistry to the diagnosis of muscular diseases].
Finocchiaro G; Rimoldi M; Carrara F; Gellera C; Bloisi W; Di Donato S
Riv Neurol; 1988; 58(1):37-44. PubMed ID: 3047847
[No Abstract] [Full Text] [Related]
56. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase.
Clark-Taylor T; Clark-Taylor BE
Med Hypotheses; 2004; 62(6):970-5. PubMed ID: 15142659
[TBL] [Abstract][Full Text] [Related]
57. Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial beta-oxidation.
Le Gouill E; Jimenez M; Binnert C; Jayet PY; Thalmann S; Nicod P; Scherrer U; Vollenweider P
Diabetes; 2007 Nov; 56(11):2690-6. PubMed ID: 17682093
[TBL] [Abstract][Full Text] [Related]
58. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.
Holloway GP; Thrush AB; Heigenhauser GJ; Tandon NN; Dyck DJ; Bonen A; Spriet LL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1782-9. PubMed ID: 17311893
[TBL] [Abstract][Full Text] [Related]
59. [What remains of Dercum's disease?].
Pouliquen A; Baize P; Lebosse J; Fellion G
Ann Med Psychol (Paris); 1984 May; 142(5):730-7. PubMed ID: 6391328
[No Abstract] [Full Text] [Related]
60. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
Vickers AE; Bentley P; Fisher RL
Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
